Nuclear Medicine - A Global Update of Market Trends & Opportunities

NEW YORK, Jan. 29 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

Nuclear Medicine - A Global Update of Market Trends & Opportunities

http://www.reportlinker.com/p0164233/Nuclear-Medicine---A-Global-Update-of-Market-Trends--Opportunities.html

Nuclear medicine facilitates accurate diagnoses of cardiac diseases, blood flow blockages, neurological disorders, and dysfunction of any major body/organ. Gamma Cameras and PET Scanners are the primary imaging devices used for nuclear medicine procedures. Though nuclear medicine faces competition from other methods, their impact is limited. Demand for diagnostic medical imaging modalities is closely interlinked to the number of diagnostic procedures. Growing awareness of PET's clinical utility and its synergistic use with other imaging modalities and ongoing shift to PET-CT imaging and SPECT-CT imaging is one of the key reasons driving the dramatic rise in procedural volumes. In addition, advancements in molecular imaging, evolution of image-guided interventions, as well as aging population continue to fuel growth in the broader medical diagnostics market.

These and other market data and trends are presented in "Nuclear Medicine: A Global Update of Market Trends & Opportunities" by BizAcumen, Inc. Our reports are designed to be most comprehensive in geographic coverage and vertical market analyses.

NUCLEAR MEDICINE BMR-1033

CONTENTS

1. METHODOLOGY 1

Study Reliability and Reporting Limitations 1

Disclaimers 2

Quantitative Techniques & Reporting Level 3

2. GLOBAL MARKET OVERVIEW AND OUTLOOK 4

Market Snapshots 4

Outlook 5

Trends and Issues 5

Market Shifts to Hybrid Imaging 5

PET Makes Inroads into Conventional Gamma Camera Market 5

Diagnostic Imaging Witnesses Dramatic Growth 5

Aging Population and Healthy Reimbursement Drive Procedure

Volumes 6

Technology Innovations Promise Bright Prospects 6

Competition 7

Leading Players in the Worldwide Nuclear Medicine Market: A-

Completive Analysis 8

3. PRODUCT FACTS 9

Nuclear Medicine 9

Gamma Cameras 10

PET Scanners 10

Research and Development 10

Philips and University Medical Center Hamburg-Eppendorf

Develop MRI/PET Imaging Tool 10

Indian Scientists Develop Low-Cost Nuclear Medicine Kit 10

4. CORPORATE DEVELOPMENTS 11

Orbotech to Acquire Danish Diagnostic Development 11

Covidien Imaging Solution Signs Agreement with BioSynthema 11

Digirad Takes Over Ultrascan 11

Triad Isotopes Acquires Three Major Nuclear Pharmacies 12

International Isotopes Acquires Stake in RadQual 12

Teleradiology and National Healthcare Group Enter into Joint

Venture 12

Philips and Bioscan Sign Marketing Agreement 12

Mubadala Signs Contract with Siemens 13

HealthCare Global and GE Healthcare Establish Advanced

Molecular Imaging- Center 13

International Atomic Energy Agency Establishes Gamma Camera

Laboratory 13

Philips Launches MOSAIC HP Imaging System 13

Digirad Launches nSPEEDsm 14

Philips Introduces PET/CT Pulmonary Toolkit 14

Siemens to Introduce New High Definition PET-CT 14

Philips Extends Availability of PET/CT Viewer to iSite PACS

Settings 15

Philips Announces Commercial Availability of JETStream

Workspace 3.0 15

Philips Launches NanoSPECT/CT 15

Philips Announces Improvements to GEMINI TF PET/CT System 15

5. MAJOR PLAYERS 16

Digirad Corporation (USA) 16

GE Healthcare Plc (The United Kingdom) 16

Mallinckrodt, Inc. (USA) 16

Molypharma S.A. (Spain) 16

Orbotech Medical Solutions Ltd. (Israel) 16

Positron Corporation (USA) 17

IS2 Medical Systems (Canada) 17

Siemens Medical Solutions USA, Inc. (USA) 17

Toshiba Medical Systems Corporation (Japan) 17

Toshiba America Medical Systems, Inc. (USA) 17

6. GLOBAL MARKET ANALYTICS 18

7. THE UNITED STATES 21

Nuclear Medicine - Key Features 21

Market Trends 21

Nuclear Medicine Procedures on the Rise 21

Upsurge in Use of PET Scanners 22

Gamma Cameras: Gaining a Niche in Cardiac Imaging 23

Nuclear Cardiology: Primary Growth Propellant 23

Shift Towards Hospital-based PET Procedures from Outpatient

Facilities 23

Growth in PET Procedure Volumes: Key Market Driver 24

Reimbursement Scenario 24

Competition 24

Gamma Cameras 24

PET Scanners 26

8. CANADA 29

Canada Faces Serious Issue over Paucity of PET Scanners 29

9. JAPAN 30

Market Scenario 30

10. EUROPE 31

a. France 34

b. Germany 35

c. The United Kingdom 36

d. Italy 38

e. Spain 39

f. Rest of Europe 40

11. ASIA-PACIFIC 41

Market Overview 41

Major Markets 41

China 41

Korea 41

12. REST OF WORLD 42

Major Markets 42

The Middle East 42

Latin America 43

EXHIBITS

Table 1: Percentage Breakdown of Leading Players in the Global

Gamma Camera Market - 2007

Table 2: Percentage Breakdown of Leading Players in the

Global PET Scanner Market -2007

Table 3: Estimated Prices of Nuclear Medicine Systems

Table 4: Global Nuclear Medicine Market by Region for the

Period 2007-2015 (Sales in US$ Million)

Table 5: Percentage Breakdown (Value Sales) of Global Nuclear

Medicine Market by Region for the Years 2008 & 2012

Table 6: Global Gamma Cameras Market by Region for the Period

2007-2015 (Sales in US$ Million)

Table 7: Percentage Breakdown (Value Sales) of Global Gamma

Cameras Market by Region for the Years 2008 & 2012

Table 8: Global PET Scanners Market by Region for the Period

2007-2015 (Sales in US$ Million)

Table 9: Percentage Breakdown (Value Sales) of Global PET

Scanners Market by Region for the Years 2008 & 2012

Table 10: Nuclear Medicine Procedures Performed in the US by

Procedure Type - 2007-2010 (in millions)

Table 11: Percentage Breakdown of Leading Players in the US

Gamma Camera Market - 2007E

Table 12: Percentage Breakdown of Leading Players in the US

Cardiology Gamma Camera Market - 2007

Table 13: Percentage Breakdown of Leading Players in the US

PET Scanner Market - 2007

Table 14: Nuclear Medicine Market by Product Segment in the

US: 2007-2015 (Sales in Units)

Table 15: Percentage Breakdown (Volume Sales) of Nuclear

Medicine Market by Product Segment in the US for the Years

2008 & 2012

Table 16: Nuclear Medicine Market by Product Segment in the

US: 2007-2015 (Sales in US$ Million)

Table 17: Percentage Breakdown (Value Sales) of Nuclear

Medicine Market by Product Segment in the US for the Years

2008 & 2012

Table 18: Nuclear Medicine Market by Product Segment in

Canada: 2007-2015 (Sales in US$ Million)

Table 19: Percentage Breakdown (Value Sales) of Nuclear

Medicine Market by Product Segment in Canada for the Years

2008 & 2012

Table 20: Nuclear Medicine Market by Product Segment in Japan:

2007-2015 (Sales in US$ Million)

Table 21: Percentage Breakdown (Value Sales) of Nuclear

Medicine Market by Product Segment in Japan for the Years

2008 & 2012

Table 22: Nuclear Medicine Market by Region in Europe:

2007-2015 (Sales in US$ Million)

Table 23: Percentage Breakdown (Value Sales) of Nuclear

Medicine Market by Region in Europe for the Years 2008 & 2012

Table 24: Nuclear Medicine Market by Product Segment in

Europe: 2007-2015 (Sales in US$ Million)

Table 25: Percentage Breakdown (Value Sales) of Nuclear

Medicine Market by Product Segment in Europe for the Years

2008 & 2012

Table 26: Nuclear Medicine Market by Product Segment in

France: 2007-2015 (Sales in US$ Million)

Table 27: Percentage Breakdown (Value Sales) of Nuclear

Medicine Market by Product Segment in France for the Years

2008 & 2012

Table 28: Nuclear Medicine Market by Product Segment in

Germany: 2007-2015 (Sales in US$ Million)

Table 29: Percentage Breakdown (Value Sales) of Nuclear

Medicine Market by Product Segment in Germany for the Years

2008 & 2012

Table 30: Percentage Breakdown of Nuclear Medicine Market by

Technology in the UK - 2004

Table 31: Nuclear Medicine Market by Product Segment in the

UK: 2007-2015 (Sales in US$ Million)

Table 32: Percentage Breakdown (Value Sales) of Nuclear

Medicine Market by Product Segment in the UK for the Years

2008 & 2012

Table 33: Nuclear Medicine Market by Product Segment in Italy:

2007-2015 (Sales in US$ Million)

Table 34: Percentage Breakdown (Value Sales) of Nuclear

Medicine Market by Product Segment in Italy for the Years 2008

& 2012

Table 35: Nuclear Medicine Market by Product Segment in Spain:

2007-2015 (Sales in US$ Million)

Table 36: Percentage Breakdown (Value Sales) of Nuclear

Medicine Market by Product Segment in Spain for the Years 2008

& 2012

Table 37: Nuclear Medicine Market by Product Segment in Rest

of Europe: 2007-2015 (Sales in US$ Million)

Table 38: Percentage Breakdown (Value Sales) of Nuclear

Medicine Market by Product Segment in Rest of Europe for the

Years 2008 & 2012

Table 39: Nuclear Medicine Market by Product Segment in

Asia-Pacific: 2007-2015 (Sales in US$ Million)

Table 40: Percentage Breakdown (Value Sales) of Nuclear

Medicine Market by Product Segment in Asia-Pacific for the

Years 2008 & 2012

Table 41: Nuclear Medicine Market by Product Segment in Rest

of World: 2007-2015 (Sales in US$ Million)

Table 42: Percentage Breakdown (Value Sales) of Nuclear

Medicine Market by Product Segment in Rest of World for the

Years 2008 & 2012

COMPANIES PROFILED

To order this report:

Medical Equipment and Supply Industry: Nuclear Medicine - A Global Update of Market Trends & Opportunities

More  Market Research Report

Check our  Company Profile, SWOT and Revenue Analysis!

SOURCE Reportlinker